THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
THRX
Delisted
THRX was delisted on the 13th of February, 2024.
51 hedge funds and large institutions have $102M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
51
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.09M | |
| 2 | +$652K | |
| 3 | +$512K | |
| 4 |
Walleye Capital
New York
|
+$277K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$181K |
Top Sellers
| 1 | -$2.2M | |
| 2 | -$1.08M | |
| 3 | -$124K | |
| 4 |
D.E. Shaw & Co
New York
|
-$58K |
| 5 |
Morgan Stanley
New York
|
-$22.6K |